To include your compound in the COVID-19 Resource Center, submit it here.

TF2: Phase I data

An open-label, Dutch Phase I trial in 20 patients showed

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE